A detailed history of Edge Capital Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Edge Capital Group, LLC holds 14,428 shares of PFE stock, worth $370,078. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,428
Previous 18,590 22.39%
Holding current value
$370,078
Previous $520,000 19.81%
% of portfolio
0.02%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $115,287 - $130,645
-4,162 Reduced 22.39%
14,428 $417,000
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $2,273 - $2,664
90 Added 0.49%
18,590 $520,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $2,278 - $2,616
-88 Reduced 0.47%
18,500 $513,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $113,351 - $147,231
-4,338 Reduced 18.92%
18,588 $535,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $40,754 - $47,637
-1,270 Reduced 5.25%
22,926 $760,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $276,065 - $319,400
-7,643 Reduced 24.01%
24,196 $887,000
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $191,553 - $249,374
4,863 Added 18.03%
31,839 $1.3 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $127,588 - $166,552
3,056 Added 12.78%
26,976 $1.38 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $36,627 - $44,712
837 Added 3.63%
23,920 $1.05 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $237,768 - $281,918
5,110 Added 28.43%
23,083 $1.21 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $42,273 - $52,381
924 Added 5.42%
17,973 $930,000
Q4 2021

Jan 19, 2022

SELL
$41.32 - $61.25 $13,800 - $20,457
-334 Reduced 1.92%
17,049 $1.01 Million
Q3 2021

Oct 26, 2021

SELL
$39.25 - $50.42 $221,605 - $284,671
-5,646 Reduced 24.52%
17,383 $748,000
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $48,514 - $54,958
-1,351 Reduced 5.54%
23,029 $902,000
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $142,098 - $160,258
-4,243 Reduced 14.82%
24,380 $883,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $105,664 - $134,361
3,157 Added 12.4%
28,623 $1.05 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $61,976 - $72,712
1,952 Added 8.3%
25,466 $935,000
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $47,318 - $57,404
-1,571 Reduced 6.26%
23,514 $769,000
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $594 - $849
22 Added 0.09%
25,085 $819,000
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $29,891 - $33,922
908 Added 3.76%
25,063 $982,000
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $165,926 - $215,157
-5,107 Reduced 17.45%
24,155 $868,000
Q2 2019

Jul 25, 2019

BUY
$36.98 - $41.52 $99,735 - $111,979
2,697 Added 10.15%
29,262 $1.27 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $388,012 - $426,296
10,347 Added 63.8%
26,565 $1.13 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $623,906 - $711,321
16,218 New
16,218 $708,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Edge Capital Group, LLC Portfolio

Follow Edge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.